Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2025-12-26 @ 4:03 AM
Study NCT ID:
NCT00885118
Status:
COMPLETED
Last Update Posted:
2014-11-25
First Post:
2009-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-04-20
First Submit QC Date:
None
Study First Post Date:
2009-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-16
Results First Submit QC Date:
None
Results First Post Date:
2014-06-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-13
Last Update Post Date:
2014-11-25
Last Update Post Date Type:
ESTIMATED